SCHEMBL20537334

SCHEMBL20537334

C[Si](C)(C)OS(=O)(=O)O.FC(F)F

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.38
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5231067 0.89
SCHEMBL28059294 0.76 ALDH1A1 (0.33) TSHR
SCHEMBL11349376 0.71 CA2 (0.47) CA2TSHRTDP1
SCHEMBL9568607 0.71 TSHR (0.44) CA2TSHRTDP1
SCHEMBL26101438 0.71 TSHR (0.35) TSHRTDP1
SCHEMBL1516355 0.70
SCHEMBL3777304 0.67 TSHR (0.47) CA2TSHRTDP1
SCHEMBL4918961 0.67 TSHR (0.47) CA2TSHRTDP1
SCHEMBL9898501 0.67 CA2 (0.35) CA2TSHR
SCHEMBL1059932 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3392259-B1 SUBSTITUTED CYCLOPENTADIENYL COBALT COMPLEX AND METHOD FOR PRODUCTION THEREOF TOSOH CORP (JP) 2023-06-07 EP disclosed
US-10336782-B2 Substituted cyclopentadienyl cobalt complex and method for production thereof, and cobalt-containing thin film and method for production thereof SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2019-07-02 US disclosed
US-20180362568-A1 SUBSTITUTED CYCLOPENTADIENYL COBALT COMPLEX AND METHOD FOR PRODUCTION THEREOF, AND COBALT-CONTAINING THIN FILM AND METHOD FOR PRODUCTION THEREOF TOSOH CORPORATION (JP) 2018-12-20 US disclosed
EP-3392259-A1 SUBSTITUTED CYCLOPENTADIENYL COBALT COMPLEX AND METHOD FOR PRODUCTION THEREOF, AND COBALT-CONTAINING THIN FILM AND METHOD FOR PRODUCTION THEREOF Tosoh Corporation (JP) 2018-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336782-B2 Substituted cyclopentadienyl cobalt complex and method for production thereof, and cobalt-containing thin film and method for production thereof SCO2, CBR3, CBR1 CA2 371/4885TSHR 2685/4885TDP1 4050/4885
US-20180362568-A1 SUBSTITUTED CYCLOPENTADIENYL COBALT COMPLEX AND METHOD FOR PRODUCTION THEREOF, AND COBALT-CONTAINING THIN FILM AND METHOD FOR PRODUCTION THEREOF SCO2, CBR3, CBR1 CA2 371/4885TSHR 2685/4885TDP1 4050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.